David Scott Jones, SVP & Chief Commercial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 69,232 shares at $22.24 ($1.6M) on 2024-01-22, disclosed to the SEC on 2024-01-24.
Open-market sale of $1.6M EYPT by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.24 | 5,416 | $120K | 7.7% |
| 2 | $22.24 | 5,416 | $120K | 7.7% |
| 3 | $22.69 | 28,750 | $652K | 41.6% |
| 4 | $22.69 | 28,750 | $652K | 41.6% |
| 5 | $25.00 | 400 | $10K | 0.6% |
| 6 | $25.00 | 500 |
| $13K |
| 0.8% |
| Total | $22.65 avg | 69,232 | $1.6M | 100% |
| Filing → |
| EYPT | SELL | 2024-01-26 | $290K | — | Filing → |